{"nct_id":"NCT06653842","title":"A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-12-20","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PVLA"]}